The Nepal digest Information about Nepal and India, tibet and more Mumbai: A US congressional panel has voiced concern on the ineffective action on quality lapses taken by its national drug regulator Food and Drug Administration (FDA) particularly in manufacturing facilities in India and China. Together, India and China supply approximately 32% of generic drugs, and nearly half of active pharmaceutical …
Read More »Drug cos on toes amid glare on USFDA
